Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins

Author(s):
Fessenden, T.B.; Stopfer, L.E.; Chatterjee, F.; Zulueta, J.; Mesfin, J.; Dumit, T.C.; Reijers, I.; Hoefsmit, E.P. (0000-0002-3989-8175); Blank, C.; White, F.; Spranger, S.
Published
2022
Publication type
Article / Letter to editor
Date issued
2022-07-12
Language
English
Publisher
BMJ Publishing Group
Is part of
Journal for ImmunoTherapy of Cancer (2022), No. 7
hdl
1887/3731157
doi
10.1136/jitc-2021-004159
URL
https://jitc.bmj.com/content/10/7/e004159